alpha-aminopyridine has been researched along with Giant Cell Tumors in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberti, L; Blay, JY; Brahmi, M; Cassier, P; Eberst, L; Karanian, M; Pissaloux, D; Tirode, F | 1 |
Chabner, B; Richon, V | 1 |
Anthony, SP; Bollag, G; Burton, EA; Chmielowski, B; Cohn, AL; Gee, C; Habets, G; Healey, JH; Hirth, P; Hsu, HH; Ibrahim, PN; Keedy, VL; Kim, MJ; Kwak, EL; Lin, PS; Marimuthu, A; Nguyen, H; Nolop, K; Peterfy, C; Puzanov, I; Ramanathan, RK; Sanftner, L; Severson, P; Shapiro, GI; Shellooe, R; Singh, AS; Staddon, AP; Tap, WD; Tong-Starksen, S; Tsang, G; van de Rijn, M; Visor, G; Von Hoff, DD; Wagner, AJ; Wainberg, ZA; Weiss, GJ; West, BL; Zhang, C; Zhang, J; Zhang, Y | 1 |
1 trial(s) available for alpha-aminopyridine and Giant Cell Tumors
Article | Year |
---|---|
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
Topics: Adult; Aged; Aminopyridines; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Female; Giant Cell Tumors; Humans; Male; Middle Aged; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Soft Tissue Neoplasms; Tendons; Tumor Burden | 2015 |
2 other study(ies) available for alpha-aminopyridine and Giant Cell Tumors
Article | Year |
---|---|
Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene.
Topics: Aminopyridines; Female; Giant Cell Tumors; Humans; Macrophage Colony-Stimulating Factor; Middle Aged; Prognosis; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Remission Induction; Synovial Membrane; Translocation, Genetic | 2018 |
Structural Approaches to Cancer Drug Development.
Topics: Aminopyridines; Female; Giant Cell Tumors; Humans; Male; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Soft Tissue Neoplasms | 2015 |